616.234.5000
Phase II colorectal cancer
clinical trial first to receive
support, scientific oversight from
VARI-SU2C
Epigenetics Dream Team
Learn More

Van Andel Research Institute and Stand Up To Cancer continue Epigenetics Dream Team

Learn More

VARI–SU2C Epigenetics Dream Team

Stephen Baylin, M.D.
The Van Andel Research Institute–Stand Up to Cancer (VARI–SU2C) Epigenetics Dream Team is a multi-institutional effort to develop new epigenetic therapies to combat cancer, and to move promising therapies to clinical trials.

Learn More